Source: Annual Congress 2005 - Therapeutic options for COPD: present and future
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Bucchioni, T. Cappelletti, G. Pozzoli, S. Galbiati, B. Dallari, L. Allegra (Milan, Italy). N-acetylcysteine reduces 8-isoprostane levels in exhaled breath condensate and serum of COPD patients. Eur Respir J 2005; 26: Suppl. 49, 214

Member's Comments

No comment yet.

Related content which might interest you: Increased 8-isoprostane in the exhaled breath condensate of down patients Source: Eur Respir J 2004; 24: Suppl. 48, 556s Year: 2004 Pretreatment levels of VEGF and 8-isoprostane in exhaled breath condensate (EBC) and serum of lung cancer patients Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008 Increased lactate concentrations in exhaled breath condensate (EBC) in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 584s Year: 2007 8-isoprostane and cys-leukotrienes in exhaled breath condensate (EBC) of children with asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002 Nitrite/nitrate in exhaled breath condensate (EBC) of patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 671s Year: 2006 Pretreatment levels of TNF-α in serum and exhaled breath condensate in patients with lung cancer Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007 TNF-α in exhaled breath condensate and in serum of scleroderma patients Source: Eur Respir J 2003; 22: Suppl. 45, 448s Year: 2003 Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004 Increased of TNF-α Levels in breath condensate and in serum of COPD subjects Source: Eur Respir J 2003; 22: Suppl. 45, 448s Year: 2003 Apocynin reduces H2O2 and NO2¯ concentrations in exhaled breath condensate of COPD patients Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011 Supplementation with antioxidants in Down syndrome: the effects on exhaled breath condensate (EBC) and serum Source: Annual Congress 2007 - Invasive and noninvasive methods to assess airway inflammation Year: 2007 8-isoprostane in breath condensate in patients with exacerbation of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001 Relationships between the concentrations of NO, IL1β, TNF-α, IL-6 in exhaled breath condensate (EBC) and lung function in patient with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 61s Year: 2005 Nitrite/nitrate levels in exhaled breath condensate are increased but exhaled nitric oxide levels were not in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 788s Year: 2006 The study of the activity of antioxidant enzymes in exhaled breath condensate (EBC) in patients with COPD Source: Virtual Congress 2020 – Cellular stress in respiratory diseases Year: 2020 Influence of smoking on indicators of free-radical oxidation in a condensate in exhaled breath condensate (EBC) at healthy and patients with bronchial asthma (BA) Source: Annual Congress 2010 - Smoking related disorders Year: 2010 Exhaled breath condensate nitrate/nitrite in asthma, COPD and healthy controls Source: Eur Respir J 2006; 28: Suppl. 50, 283s Year: 2006 Relationship of inflamamatory markers in blood and exhaled breath condensate in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 283s Year: 2006 Endogenous and exogenous metabolites in exhaled breath condensate in asthma Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Inflammatory cytokines in exhaled breath condensate (EBC) of exacerbated COPD patients Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008